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Mice over-expressing human erythropoietin 
indicate that erythropoietin enhances expression 
of its receptor via up-regulated Gata1 and Tal1
The development of medullary hematopoiesis is char-
acterized by a specific expression profile of hematopoiet-
ic transcription factors, including GATA transcription fac-
tors. At mid-gestation, when hematopoiesis is newly
established in the bone marrow of human fetuses, initial-
ly high GATA2 expression becomes subsequently down-
regulated, while GATA1 expression increases in parallel.1
Both transcription factors bind to overlapping sets of
hematopoietic downstream target genes, often at distinct
sites, to regulate the balance between proliferation and
differentiation. Chromatin occupancy by GATA1 and
GATA2 can change in the course of hematopoietic differ-
entiation, leading to the so-called GATA switch.2 Thus, a
spatio-temporal regulation of GATA1 or GATA2 activities
is required within lineage-specific differentiation. During
erythroid differentiation GATA1 expression peaks at the
level of colony-forming units (CFU-E),3 where erythro-
poietin (Epo) exerts most specifically its effects, but
blocks terminal maturation if constitutively over-
expressed.4 In CFU-E progenitors, the Epo receptor (EpoR)
gene is a prerequisite downstream target of GATA1 that
activates EpoR expression in concert with several co-fac-
tors.5 Notably, EpoR-mediated signals in turn strongly
enhance GATA1 gene expression in erythroid progenitor
cells in vitro.5,6 There is also in vitro evidence that Epo
induces EpoR expression by activating the GATA1-medi-
ated EpoR transcription.5
An alternate link between Epo and excessive erythro-
poiesis, which includes GATA1 activity, is given by the
basic helix-loop-helix protein TAL1 (T-cell Acute
Leukemia-1 transcription factor).7 In vitro, Epo stimulates
expression of TAL1 and phosphorylation of its protein
products.8 TAL1 directly up-regulates EpoR transcription
and increases by nucleosome shifting the association of a
transcription factor complex that includes GATA1, TAL1,
LMO2 (Lim-Only Protein-2) and LDB2 (Lim-Domain
Binding Protein 2), to a regulatory domain in the 5’
untranslated region of the EpoR gene.7 In this way, TAL1
causes hypersensitivity to Epo and promotes excessive
erythrocytosis.
Transgenic mice, constitutively over-expressing the
human EPO (hEPO) gene (tg6 mice), represent a valuable
model to further elucidate the in vivo implication of Epo
in fine-tuning transcriptional activities that may modu-
late EpoR expression and explain the gradual increase in
erythropoiesis from normal hematocrit levels at birth to
maximum hematocrit levels of up to 90% after several
weeks.9
Our analysis indicates that the two erythroid master
regulators Gata1 and Tal1 co-operatively act as develop-
mental-stage specific enhancers of EpoR expression in
response to constitutive EPO overexpression.
While Gata1 mRNA expression in the newly estab-
lished bone marrow of wild-type mice declined with
increasing postnatal age (Figure 1A), its expression
remained on a constant and significantly higher level in
hEPO over-expressing tg6 mice. However, Gata2 mRNA
expression remained similar in hEPO over-expressing tg6
mice compared to controls throughout all ages (Figure
1B). In hEpo over-expressing tg6 mice, EpoR mRNA
expression significantly increased with age, but declined
in control animals (Figure 1C). 
The significant upregulation of Gata1 and EpoR mRNA
expression in hEPO over-expressing tg6 mice was con-
firmed by analyzing the spleen as a major source of
hematopoiesis (Figure 2A and B). To further dissect the
complexity of changes in the transcriptional network, the
analysis of Myb mRNA expression served as marker for
adult definitive erythroblasts,10 showing significantly
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Figure 1. Longitudinal expression of Gata1, Gata2 and EpoR
mRNA transcripts in the bone marrow of tg6 and wild-type mice
(at postnatal Day 7 (d7), d21, d49). The transgenic mouse line tg6,
in which the hEPO transgene is transmitted in autosomal domi-
nant manner, was bred at the Institute of Veterinary Physiology,
University of Zurich. The protocol was approved by the local
Institutional Review Board and all procedures were performed
according to the Swiss Animal Protection Law. To obtain
hematopoietic cells from the bone marrow, femurs and tibias of 7,
21 and 49 day-old mice were prepared and flushed with ice-cold
PBS. Bone marrow specimens of each single animal were pooled.
Total mRNA was purified following the TRIzol protocol (Invitrogen,
Carlsbad, CA, USA), and cDNA was generated by a High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems, Foster City,
CA, USA). 5'-FAM-labeled probes were used for detection of murine
Gata1 (Assay ID: Mm00484678_m1), Gata2 (Mm00492301_m1)
or EpoRmRNA (Mm00438760_m1) transcripts and b-actin (ACTB
4352664-0602004; all from Applied Biosystems) by real-time
PCR technology with TaqMan 2× Universal PCR Mastermix Mix as
recommended in the manufacturer’s protocol (Applied
Biosystems). Data (mean and standard deviation) are presented
as ratio between Gata1, Gata2 or EpoR mRNA transcript and 
b-actinmRNA transcript levels (n=4-6 sets). All reactions were per-
formed in duplicates, and all four transcripts were analyzed in par-
allel. Statistical significance was examined by one-way ANOVA
post hoc comparisons. P<0.05 was considered significant.
*P<0.05; ***P<0.001. 
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(Figure 2B). In contrast, expression levels of both Tal1 and
Lmo2 were significantly up-regulated in hEPO over-
expressing tg6 mice (Figure 2A). 
The longitudinal analysis in the developing bone mar-
row also indicated increasing Tal1 mRNA levels, which
were tightly correlated with Gata1 mRNA expression
(Figure 2C). 
The combined data confirm that Epo recruits the ery-
throid transcriptional network to enhance its erythropoi-
etic effect by mechanisms that directly induce EpoR
upregulation and hypersensitivity to Epo in vivo. While
such effects, predominately mediated by Gata1 and Tal1,
are attributed to the stage of BFU-E (burst-forming unit
erythoid) and CFU-E, the reduced expression of Myb in
the hEPO over-expressing tg6 mice may reflect its prereq-
uisite role for Epo-induced differentiation commitment.11
However, evidence is given that Gata1 protein induces
EpoR expression by activating the 5’ EpoR promoter.5 In
response to acute anemic stress, the Epo-induced increase
in the CFU-E population is concomitant with upregula-
tion of EpoR, Gata1 and Bcl-XL expression in the murine
bone marrow.12 Thus, Epo stimulates erythropoiesis not
only by activation of ‘classical’ downstream signaling,
but also further enhances its effect by the Gata1-induced
upregulation of EpoR expression. As recently reported,
Epo regulates GATA1 through protein kinase D activa-
tion, promoting histone deacetylase 5 dissociation from
GATA1, and subsequent GATA1 acetylation.13 This post-
translational modification resulted in increased DNA-
binding activity of GATA1,14 which may contribute to
enhanced EpoR expression. Such GATA1 function is high-
ly specific for erythroid precursor cells, because on acti-
vated CD4-positive lymphocytes EpoR expression
depends only on the transcription factor Sp1, but not on
GATA1.15
The lack of any differences in Gata2 expression indi-
cates that Epo does not directly interfere with the spatio-
temporal regulation of Gata1 or Gata2 activities within
the erythroid differentiation. The observation that Gata1
expression in the developing bone marrow of control
mice declined with increasing age, while its expression in
hEPO over-expressing tg6 mice remained constantly high,
raises the question as to whether a critical threshold of
the Gata1 induction has been reached during the obser-
vation period, and whether additional regulators are
involved in the process of developing excessive erythro-
poiesis under constitutive hEPO overexpression. Indeed,
an approximately 50-fold increase of Tal1 mRNA expres-
sion in adult hEPO over-expressing tg6 mice as well the
tight correlation between gradually increasing Gata1 and
Tal1 mRNA expression levels in their developing bone
marrow direct to another mechanism of EpoR regulation.
This mechanism has been previously explored in ery-
throid progenitor cells from a patient with excessive ery-
throcytosis.7 While Tal1 can directly induce EpoR expres-
sion by binding to E-box motifs in the 5’-untranslated
EpoR locus, Tal1 may synergize with Gata1 activity by
increasing the association of the GATA1-TAL1-LMO2-
LDB2 transcription factor complex to 5’-GATA and 3’-E-
box motifs flanking the EpoR transcription start site.7
In summary, longitudinal analysis of hEPO over-
expressing tg6 mice provides novel in vivo information
that Epo directly tunes activation of the erythroid tran-
scriptional master regulators Gata1 and Tal1 to enhance
EpoR gene expression. When a selective GATA1 inhibitor
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Figure 2. (A and B) Expression analyses of Gata1, Lmo2,
Tal1 (A), and Myb and EpoR mRNA transcripts (B) in the
spleen of 6- to 8-week-old tg6 and wild-type mice (n=4
sets). (C) Relation between Gata1 and Tal1 mRNA expres-
sion in the bone marrow of tg6 and wild-type mice at differ-
ent ages (postnatal Day 7 (d7), d21, d49). Q-PCR analysis
was performed as described above using TaqMan Gene
Expression Assays for Gata1 (Mm00484678_m1), Lmo2
(Mm01281680_m1), Tal1 (Mm01187033_m1) as well as
Myb (Mm00501741_m1). All mRNA row data were normal-
ized to b-actin transcript levels. Statistical significances
were determined by using the unpaired t-test. (n=2 pairs;
*P<0.05; **P<0.01: ***P<0.001).
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eventually becomes available, these data may be impor-
tant for developing novel therapeutic concepts for chron-
ic polycythemia.
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